September 16, 2025 11:45 ET | Source: Transgene S.A. Transgene S.A.
2025 Half-year financial information
Attachment
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2026
Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate at WCID
